EP1434556A1 - Preparations cosmetiques et / ou pharmaceutiques - Google Patents

Preparations cosmetiques et / ou pharmaceutiques

Info

Publication number
EP1434556A1
EP1434556A1 EP02801312A EP02801312A EP1434556A1 EP 1434556 A1 EP1434556 A1 EP 1434556A1 EP 02801312 A EP02801312 A EP 02801312A EP 02801312 A EP02801312 A EP 02801312A EP 1434556 A1 EP1434556 A1 EP 1434556A1
Authority
EP
European Patent Office
Prior art keywords
ether
alkyl
fatty acid
fatty
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02801312A
Other languages
German (de)
English (en)
Inventor
Werner Seipel
Lars Zander
Thomas Albers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis IP Management GmbH
Original Assignee
Cognis Deutschland GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis Deutschland GmbH and Co KG filed Critical Cognis Deutschland GmbH and Co KG
Publication of EP1434556A1 publication Critical patent/EP1434556A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/604Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/737Galactomannans, e.g. guar; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Definitions

  • the invention relates to surfactant preparations containing glyceride monoalkyl ethers and the use of glyceride monoalkyl ethers as refatting agents in surfactant preparations.
  • Preparations that are used to clean and care for human skin and hair generally contain one or more surface-active substances, in particular those based on anionic or amphoteric surfactants. Since the sole use of surfactants would dry out the skin and hair too much, it is generally customary to add moisturizing substances to such agents. On the one hand, surfactant formulations should have a cleansing effect, on the other hand, they should still leave a moisturizing protective film on the skin. Especially with "rinse-off" formulations, there is the difficulty that refatting substances can also be rinsed off and their effects can be inadequate. The exchange of undesirable fat components on the skin that are to be subject to the cleaning process against refatting components on the skin should remain or should be stored in the upper layers of the skin is subject to a delicate balance.
  • Patent EP 0 547 727 B1 discloses glycerol monoalkyl ethers as refatting agents for skin disinfectants. Since these are "leave on" formulations, glycerol monoethers can be used regardless of their lipophilicity. Short-chain glyceryl monoalkyl ethers in low concentrations are preferred in these formulations in order to exploit good alcohol solubility and an additional antimicrobial activity. Nevertheless, the skin oil content decreases after using it significantly over time and only after repeated use, a higher fat content remains than with conventional moisturizing disinfectants.
  • surfactant formulations contain gyceryl monoalkyl esters as refatting agents, to be found, for example, in German patents DE 41 39 935 C2 and DE 19543633 C2. These compositions contain relatively high amounts of fatty acid monoglycerides, since a noticeable proportion is rinsed off again by the cleaning properties.
  • US Pat. No. 4,690,818 describes described in cosmetic cleaning agents as a moisturizer for skin and hair glyoxylated ether. However, in this case the moisturizing effect is based on a water-binding effect, not on a lipid-replenishing effect, which keeps the water in the skin much longer through occlusion.
  • the object of the invention was therefore to provide "rinse-off" formulations with a good cleaning effect and, at the same time, a refatting effect which is improved compared to the prior art and which leave a pleasant feeling on the skin, have good dermatological compatibility and are easy to prepare.
  • the refatting agents used in the preparations should not reduce the viscosity.
  • the invention relates to cosmetic and / or pharmaceutical preparations containing
  • the selected glycerol monoalkyl ethers are known substances that can be prepared using the relevant methods of preparative organic chemistry. Mixtures of mono-, di- and triethers are generally obtained during production.
  • the glycerol monoalkyl ethers used in the present invention are therefore those fatty acid mono- / di- / triglyceride ethers which contain a mono fraction of at least 80% by weight, preferably at least 90% by weight and particularly preferably at least 95% by weight. They follow formula (I) I
  • R 1 represents an unbranched or branched alkyl and / or alkenyl radical having 6 to 18 carbon atoms, preferably 8 to 16 carbon atoms and particularly preferably 12 to 14 carbon atoms.
  • the glyceryl monoalkyl ethers are used in the agents according to the invention in amounts of 0.1 to 10% by weight, preferably 1 to 5% by weight and particularly preferably 2 to 3% by weight.
  • Nonionic, anionic, cationic and / or amphoteric or zwitterionic surfactants may be present as surface-active substances, the proportion of which is usually about 1 to 90% by weight and preferably 5 to 70% by weight and particularly preferably 10 to 50% by weight
  • Typical examples of anionic surfactants are soaps, alkylbenzene sulfonates, alkane sulfonates, olefin sulfonates, alkyl ether sulfonates, glycerin ether sulfonates, methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerin ether sulfates, fatty acid ether sulfates, hydroxymether sulfate ethersulfates, hydroxymether sulfate, and dialkyl sulfosuccinates, mono- and dialkyl sul
  • anionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycides, mixed ethers or mixed formals, optionally partially oxidized alk (en) yl oligoglycosides or especially glucoramic acid protein derivatives, fatty acid glucoramides, vegetable glucoronic acid protein derivatives, based on wheat), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides.
  • nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • Typical examples of cationic surfactants are quaternary ammonium compounds and ester quats, in particular quaternized fatty acid alkanolamine ester salts.
  • Typical examples of amphoteric or zwitterionic surfactants are alkyl betaines, alkyl amido betaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines. The surfactants mentioned are exclusively known compounds.
  • J.Falbe ed.
  • Surfactants in Consumer Products Springer Verlag, Berlin, 1987, pp. 54-124
  • J.Falbe ed.
  • Catalysts, surfactants and mineral oil additives Thieme Verlag, Stuttgart , 1978, pp. 123-217.
  • Typical examples of particularly suitable mild, ie particularly skin-compatible, surfactants are fatty alcohol polyglycol ether, Monogly- ceridsulfate, mono- and / or dialkyl sulfosuccinates, fatty acid taurides, fatty acid glutamates, ⁇ -olefin sulfonates, ethercarboxylic acids, alkyl oligoglucosides, fatty acid glucamides, alkylamidobetaines, amphoacetals and / or protein fatty acid condensates , the latter preferably based on wheat proteins.
  • Particularly preferred surfactants are alkyl and / or alkenyl oligoglycosides and / or betaines and / or alkyl ether sulfates.
  • Alkyl and alkenyl oligoglycosides which are used as particularly preferred surfactants, are known nonionic surfactants which follow the formula (II)
  • R 2 is an alkyl and / or alkenyl radical having 4 to 22 carbon atoms
  • G is a sugar radical having 5 or 6 carbon atoms
  • p is a number from 1 to 10.
  • the alkyl and / or alkenyl oligoglycosides can be derived from aldoses or ketoses with 5 or 6 carbon atoms, preferably glucose.
  • the preferred alkyl and / or alkenyl oligoglycosides are thus alkyl and / or alkenyl oligoglucos.de.
  • the index number p in the general formula (II) indicates the degree of oligomerization (DP), i.e. H. the distribution of mono- and oligoglycosides is on and stands for a number between 1 and 10.
  • Alkyl and / or alkenyl oligoglycosides with an average degree of oligomerization p of 1.1 to 3.0 are preferably used. From an application point of view, preference is given to those alkyl and / or alkenyl oligoglycosides whose degree of oligomerization is less than 1.7 and in particular between 1.2 and 1.4.
  • the alkyl or alkenyl radical R 1 can be derived from primary alcohols having 4 to 11, preferably 8 to 10, carbon atoms. Typical examples are butanol, capro alcohol, caprylic alcohol, capric alcohol and undecyl alcohol and their technical mixtures, such as those used in the hydrogenation of technical fatty acid methyl esters or in the course of the hydrogenation of aldehydes from the Roelen's oxosynthesis can be obtained.
  • the alkyl or alkenyl radical R 1 can also be derived from primary alcohols having 12 to 22, preferably 12 to 14, carbon atoms.
  • Typical examples are lauryl alcohol, myristyl alcohol, cetyl alcohol, palm oleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, brassidyl alcohol and the technical mixtures described above, which can be obtained as well as their technical mixtures.
  • Alkyl oligoglucosides based on hydrogenated Ci2 / i4 coconut alcohol with a DP of 1 to 3 are preferred.
  • alkyl and / or alkenyl oligoglycosides are used in the agents according to the invention.
  • Fatty alcohols are to be understood as primary aliphatic alcohols of the formula (III)
  • R 3 represents an aliphatic, linear or branched hydrocarbon radical having 6 to 22 carbon atoms and 0 and / or 1, 2 or 3 double bonds.
  • Typical examples are capo alcohol, caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolenyl alcohol, linolenyl alcohol, linoleyl alcohol and their technical mixtures, which are obtained, for example, in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from Roelen's oxosynthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols.
  • fatty alcohols with 12 to 18 carbon atoms such as coconut, palm, palm kernel or tallow fatty alcohol, are preferred.
  • fatty alcohols with 12 to 14 carbon atoms are particularly preferably used.
  • the fatty alcohols have the advantage that the incorporation of the glycerol monoethers can be significantly improved.
  • the preparations according to the invention are distinguished by a high cleaning capacity and excellent refatting properties. They are well tolerated by dermatology, liquid and pumpable and can be prepared cold in the form of a premix when fatty alcohols are added.
  • This premix contains 50 to 90% by weight of glycerol monoalkyl ether and 10 to 50% by weight of fatty alcohols, preferably 60 to 80% by weight of glycerol monoalkyl ether and 20 to 35% by weight of fatty alcohols, particularly preferably 65 to 75% by weight of glycerol monoalkyl ether and 25 to 40% by weight of fatty alcohols and particularly preferably 70% by weight of glycerol monoalkyl ether and 30% by weight of fatty alcohols.
  • the fatty alcohols used have chains in a length of 6 to 22, preferably 12 to 18 and particularly preferably 12 to 14 carbon atoms.
  • the advantage of compounding is cold processing. In contrast to direct incorporation at at least 60 ° C, the compound is added to a formulation without heating. The compound itself is mixed at 40 to 45 ° C.
  • Another object of the invention therefore relates to their use of glycerol monoalkyl ethers and combinations of glycerol monoalkyl ethers with fatty alcohols as refatting agents in surfactant formulations, for example for the area of hair and body care.
  • Embodiments of the cosmetic and / or pharmaceutical preparations according to the invention contain: a) 0.1-10% by weight glycerol monoalkyl ether b) 1-90% by weight anionic and / or nonionic and / or cationic and / or amphoteric and / or zwitterionic surfactants and c ) 0-10% by weight fatty alcohols, in particular a) 1-5% by weight glycerol monoalkyl ether, b) 5-70% by weight anionic and / or nonionic and / or cationic and / or amphoteric and / or zwitterionic surfactants and c) 0 5% by weight of fatty alcohols, preferably a) 2 to 3% by weight of glycerol monoalkyl ether, b) 10 to 50% by weight of anionic and / or nonionic and / or cationic and / or amphoteric and / or zwitterionic surfactants and c)
  • the cosmetic and / or pharmaceutical preparations mentioned can, as further auxiliaries and additives, emulsifiers, pearlescent waxes, consistency enhancers, thickeners, polymers, silicone compounds, lecithins, phospholipids, biogenic active substances, antioxidants , Anti-dandruff agents, film formers, hydrotropes, solubilizers, preservatives, perfume oils, dyes and the like.
  • Suitable emulsifiers are nonionic surfactants from at least one of the following groups:
  • Partial esters of polyglycerol (average degree of self-condensation 2 to 8), polyethylene glycol (molecular weight 400 to 5000), trimethylolpropane, pentaerythritol, sugar alcohols (e.g. sorbitol), alkyl glucosides (e.g. methyl glucoside, butyl glucoside, lauryl glucoside) and polyglucosides saturated (e.g. cellulose) unsaturated, linear or branched fatty acids with 12 to 22 carbon atoms and / or Hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 moles of ethylene oxide;
  • Block copolymers e.g. Polyethylene glycol 30 dipolyhydroxystearate;
  • Polymer emulsifiers e.g. Pemulen types (TR-1, TR-2) from Goodrich;
  • the adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols or with castor oil are known, commercially available products. These are mixtures of homologs whose average degree of alkoxylation is the ratio of the amounts of ethylene oxide and / or propylene oxide and substrate, with which the addition reaction is carried out.
  • Ci2 / ⁇ s fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known from DE 2024051 PS as refatting agents for cosmetic preparations.
  • Suitable partial glycerides are hydroxystearic acid monoglyceride, stearic acid diglyceride hydroxy, isostearic acid, Isostearinklarediglycerid, ⁇ lklaremonogly- cerid, oleic acid diglyceride, Ricinolklaremoglycerid, Ricinolklarediglycerid, Linolklarediglycerid, LinolenTalkremonoglycerid, Linolenchurediglycerid, lycerid Linolkladremonoglycerid Erucaklaremonoglycerid Erucaklared ig, Weinklaremonoglycerid, Weinklarediglycerid, Citronenklamonoglycerid, Citronendiglycerid, ⁇ pfelklamonoglycerid, Malic acid diglyceride and its technical mixtures, which may still contain small amounts of triglyceride from the manufacturing process. Addition products of 1 to 30, preferably
  • sorbitan sorbitan As sorbitan sorbitan, sorbitan sesquiisostearate, sorbitan diisostea- get advice, sorbitan triisostearate, sorbitan monooleate, sorbitan dioleate, Sorbitantrio- leat, Sorbitanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmo- noricinoleat, Sorbitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, sorbitan hydroxystearate, Sorbitansesquihydroxystearat , Sorbitan dihydroxystearate, sorbitan trihydroxy stearate, sorbitan monotartrate, sorbitan sesqui-tartrate, sorbitan ditartrate, sorbitan tritartrate, sorbitan monocitrate,
  • Typical anionic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as, for example, palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as, for example, azelaic acid or sebacic acid.
  • Zwitterionic surfactants can also be used as emulsifiers.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example coconut acylaminopropyldimethylammonium glycinate, and 2-alkyl-3-glycate -carboxylmethyl-3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethyl carboxymethylglycinate.
  • betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glyc
  • Suitable emulsifiers are ampholytic surfactants.
  • Ampholytic surfactants are surface-active compounds which, in addition to a C ⁇ / i ⁇ -alkyl or acyl group, contain at least one free amino group and at least one -COOH or -S0 3 H group in the molecule and are capable of forming internal salts.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkyl sarcosines, 2-alkylaminopropionic acids and Alkylaminoacetic acids each with about 8 to 18 carbon atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C12.i8-acylsarc.osine.
  • cationic surfactants are also suitable as emulsifiers, those of the esterquat type, preferably methylquaternized difatty acid triethanolamine ester salts, being particularly preferred.
  • Pearlescent waxes are: alkylene glycol esters, especially ethylene glycol distearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polyvalent, optionally hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which have a total of at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or polyols with 2 to 15 carbon atoms
  • Suitable consistency agents are primarily fatty alcohols or hydroxyfatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred.
  • Suitable thickeners are, for example, Aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and hydroxypropyl cellulose, and also higher molecular weight polyethylene glycol mono- and - diesters of fatty acids, polyacrylates, (e.g. Carbopole® and Pemulen types from Goodrich; Synthalene® from Sigma; Keltrol types from Kelco; Sepigel types from Seppic; Salcare types from Allied Colloids), polyacrylamides, polymers, polyvinyl alcohol and polyvinylpyrrolidone.
  • Aerosil types hydrophilic silicas
  • polysaccharides in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and hydroxypropyl
  • Bentonites such as Bentone® Gel VS-5PC (Rheox), which is a mixture of cyclopentasiloxane, disteardimonium hectorite and propylene carbonate, have also proven to be particularly effective.
  • Surfactants such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as, for example, pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides and electrolytes such as sodium chloride and ammonium chloride are also suitable.
  • polymers such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as, for example, pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligogluco
  • Suitable cationic polymers are, for example, cationic cellulose derivatives, e.g. a quaternized hydroxyethyl cellulose available under the name Polymer JR 400® from Amerchol, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinyl pyrrolidone / vinyl imidazole polymers such as e.g.
  • Luviquat® condensation products of polyglycols and amines, quaternized collagen polypeptides, such as lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, e.g. Amodimethicones, copolymers of adipic acid and dimethylaminohydroxypropyldiethylenetriamine (Cartaretine® / Sandoz), copolymers of acrylic acid with dimethyldiallylammonium chloride (Merquat® 550 / Chemviron), polyaminopolyamides, e.g.
  • cationic chitin derivatives such as quaternized chitosan, optionally microcrystalline, condensation products of dihaloalkylene, such as e.g. Dibromobutane with bisdialkylamines, e.g. Bis-dimethylamino-1, 3-propane, cationic guar gum, e.g. Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from Celanese, quaternized ammonium salt polymers such as e.g. Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 from Miranol.
  • dihaloalkylene such as e.g. Dibromobutane with bisdialkylamines, e.g. Bis-dimethylamino-1, 3-propane
  • cationic guar gum e.g. Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from Celanese
  • quaternized ammonium salt polymers such as e.g. Mira
  • Anionic, zwitterionic, amphoteric and nonionic polymers include, for example, vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobomylacrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and their esters, non-crosslinked acrylamide acrylamide and polyethylenethacrylate acrylates and non-crosslinked acrylamide acrylamide and polyamides / Acrylate copolymers, octylacrylamide / methyl methacrylate / tert-butylaminoethyl methacrylate / 2-hydroxypropyl methacrylate copolymers, polyvinylpyrrolidone, vinylpyrrolidone / vinyl acetate copolymers,
  • Vinyl pyrrolidone / dimethylaminoethyl methacrylate / vinyl caprolactam terpolymers as well as optionally derivatized cellulose ethers and silicones in question.
  • Other suitable polymers and thickeners are in Cosm.Toil. 108, 95 (1993).
  • Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine-, glycoside- and / or alkyl-modified silicone compounds, which can be both liquid and resinous at room temperature.
  • Simethicones which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates, are also suitable.
  • a detailed overview of suitable volatile silicones can also be found by Todd et al. in Cosm.Toil. 91, 27 (1976).
  • biogenic active substances are tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, (deoxy) ribonucleic acid and its fragmentation products, ß-glucans, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudocleamides, extracts of essential oils, essential extracts such as To understand prunus extract, Bambaranus extract and vitamin complexes.
  • Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • Piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-thmythylpentyl) -2- (IH) -pyridinone monoethanolamine salt), Baypival® (Climbazole), Ketoconazol®, (4-acetyl-1 - ⁇ - 4- [2- (2.4-dichlorophenyl) r-2- (1 H -imidazol-1-ylmethyl) -1, 3-dioxylan-c-4-ylmethoxyphenyl ⁇ piperazine, ketoconazole, elubiol, selenium disulfide, sulfur colloidal , Sulfur polyglycol sorbitan monooleate, sulfur ricinol polyethylenate, sulfur tar distillates, salicylic acid (or in combination with hexachlorophene), undexylenic acid monoethanolamide sulfosuccinate Na salt, Lamepon® UD (protein undecylenic acid / condensation ion
  • Hydrotropes such as ethanol, isopropyl alcohol, or polyols can also be used to improve the flow behavior.
  • Polyols that come into consideration here preferably have 2 to 15 carbon atoms and at least two hydroxyl groups.
  • the polyols can also contain further functional groups, in particular amino groups, or be modified with nitrogen. Typical examples are
  • Alkylene glycols such as ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons;
  • Methyl compounds such as in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
  • Dialcohol amines such as diethanolamine or 2-amino-1, 3-propanediol.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid, as well as the silver complexes known under the name Surfacine® and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Ordinance.
  • Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), wood (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme), Needles and twigs (spruce, fir, pine, mountain pine), resins and balms (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethyl methylphenylglycinate, allylcyclohexyl benzylatepylpropionate, allyl cyclohexyl propyl pionate.
  • the ethers include, for example, benzyl ethyl ether, the aldehydes, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, Hydroxycitronellal, Lilial and Bourgeonal, to the ketones eg the Jonone, ⁇ -isomethylionone and methylcedrylketone, to the alcohols anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons and mainly include the terpenes balsams.
  • the aldehydes for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, for example sageiol, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil.
  • Suitable flavors are, for example, peppermint oil, spearmint oil, anise oil, star anise oil, caraway oil, eucalyptus oil, fennel oil, lemon oil, wintergreen oil, clove oil, menthol and the like.
  • the dyes which can be used are those substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes” by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. Examples are cooking illerot A (Cl 16255), patent blue V (C.1.42051), indigotine (C.1.73015), chlorophyllin (C.1.75810), quinoline yellow (CI47005), titanium dioxide (C.1.77891), indanthrene blue RS (Cl 69800) and madder varnish (CI58000). Luminol may also be present as the luminescent dye. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • TEWL transepidermal water loss
  • defined skin pieces were treated with the different test solutions at 40 ° C over a period of 30 min and the TEWL value was determined gravimetrically.
  • the test solutions were mixtures of 17% by weight of Plantapon® PS 10 (sodium lauryl ether sulfate and lauryl glycoside, Cognis Düsseldorf), each with 1.5% by weight of fatty acid partial glycerides or glycerol ether (see Table 1) in preserved water (WAS 10% by weight) .%).
  • the pH was adjusted to 5.5 with citric acid.
  • Table 1 The results are summarized in Table 1. The lower the value, the better the dermatological tolerance.
  • the combability of treated hair strands was examined.
  • the strands were medium-blonded before the zero measurement.
  • the test formulations (1 g / 1 g hair) were applied under standard conditions (38 ° C., 1 liter / min)
  • the glycerol monocapryl ether compound consists of 70% by weight glycerol monocapryl ether and 30% by weight Lorol® special A (INCI: Lauryl Alcohol) II. Recipe examples - usage limit up to turbidity
  • the glycerol monocapryl ether compound consists of 70% by weight glycerol monocapryl ether and 30% by weight Lorol® special A (INCI: Lauryl Alcohol)

Abstract

Préparations qui contiennent (a) 0,1 à 5 % en poids de monoalkyléthers de glycérine et (b) 0,1 à 90 % en poids de tensioactifs anioniques et / ou cationiques et / ou amphotères et / ou zwitterioniques et éventuellement (c) 0 à 5 % en poids d'alcools gras. La présente invention concerne également l'utilisation de monoalkyléthers de glycérine en tant qu'agents surgraissants dans des formulations tensioactives.
EP02801312A 2001-10-13 2002-10-04 Preparations cosmetiques et / ou pharmaceutiques Withdrawn EP1434556A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10150728A DE10150728A1 (de) 2001-10-13 2001-10-13 Kosmetische und/oder pharmazeutische Zubereitungen
DE10150728 2001-10-13
PCT/EP2002/011118 WO2003032931A1 (fr) 2001-10-13 2002-10-04 Preparations cosmetiques et / ou pharmaceutiques

Publications (1)

Publication Number Publication Date
EP1434556A1 true EP1434556A1 (fr) 2004-07-07

Family

ID=7702498

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02801312A Withdrawn EP1434556A1 (fr) 2001-10-13 2002-10-04 Preparations cosmetiques et / ou pharmaceutiques

Country Status (5)

Country Link
US (1) US20040197294A1 (fr)
EP (1) EP1434556A1 (fr)
JP (1) JP2005509617A (fr)
DE (1) DE10150728A1 (fr)
WO (1) WO2003032931A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2601463T3 (es) 2002-04-22 2017-02-15 The Procter & Gamble Company Composiciones para la higiene personal que comprenden un material que contiene cinc en una composición tensioactiva acuosa
US8491877B2 (en) 2003-03-18 2013-07-23 The Procter & Gamble Company Composition comprising zinc-containing layered material with a high relative zinc lability
US8367048B2 (en) 2002-06-04 2013-02-05 The Procter & Gamble Company Shampoo containing a gel network
US8470305B2 (en) * 2002-06-04 2013-06-25 The Procter & Gamble Company Shampoo containing a gel network
US8349301B2 (en) 2002-06-04 2013-01-08 The Procter & Gamble Company Shampoo containing a gel network
US8361448B2 (en) 2002-06-04 2013-01-29 The Procter & Gamble Company Shampoo containing a gel network
US8349302B2 (en) 2002-06-04 2013-01-08 The Procter & Gamble Company Shampoo containing a gel network and a non-guar galactomannan polymer derivative
US9381382B2 (en) 2002-06-04 2016-07-05 The Procter & Gamble Company Composition comprising a particulate zinc material, a pyrithione or a polyvalent metal salt of a pyrithione and a gel network
US8361450B2 (en) * 2002-06-04 2013-01-29 The Procter & Gamble Company Shampoo containing a gel network and a non-guar galactomannan polymer derivative
WO2005063172A2 (fr) * 2005-03-24 2005-07-14 Beiersdorf Ag Preparation tensioactive a endommagement enzymatique reduit
EP2274262B1 (fr) * 2008-03-13 2018-08-29 Council of Scientific & Industrial Research Procédé de préparation d éthers de type alkylglycérols primaires utiles en tant qu'additif pour biocarburants dérivé du glycérol
US8933134B2 (en) 2010-06-09 2015-01-13 L'oreal Compositions containing agar and a softening agent
EP2763748B1 (fr) 2011-10-07 2017-07-26 The Procter and Gamble Company Composition de shampoing contenant un réseau de gel
US10806688B2 (en) 2014-10-03 2020-10-20 The Procter And Gamble Company Method of achieving improved volume and combability using an anti-dandruff personal care composition comprising a pre-emulsified formulation
US9993404B2 (en) 2015-01-15 2018-06-12 The Procter & Gamble Company Translucent hair conditioning composition
CN108366934B (zh) * 2015-12-18 2021-09-07 莱雅公司 在施加期间具有颜色转变的组合物
CN108472223A (zh) 2016-01-20 2018-08-31 宝洁公司 包含单烷基甘油基醚的毛发调理组合物
US10945935B2 (en) 2016-06-27 2021-03-16 The Procter And Gamble Company Shampoo composition containing a gel network
JP7274507B2 (ja) 2018-06-05 2023-05-16 ザ プロクター アンド ギャンブル カンパニー 透明な洗浄組成物
MX2021005464A (es) 2018-12-14 2021-06-18 Procter & Gamble Composicion de champu que comprende microcapsulas de tipo lamina.
US11896689B2 (en) 2019-06-28 2024-02-13 The Procter & Gamble Company Method of making a clear personal care comprising microcapsules
CN114981016A (zh) 2020-02-14 2022-08-30 宝洁公司 具有悬浮在其中的美学设计的适于储存液体组合物的瓶子
US11633072B2 (en) 2021-02-12 2023-04-25 The Procter & Gamble Company Multi-phase shampoo composition with an aesthetic design

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57120510A (en) * 1981-01-19 1982-07-27 Kao Corp Hair cosmetic
JPS57119998A (en) * 1981-01-20 1982-07-26 Kao Corp Shampoo composition
JPS6013706A (ja) * 1983-07-05 1985-01-24 Kao Corp パ−ル剤分散液
JP3340126B2 (ja) * 1990-03-02 2002-11-05 株式会社資生堂 非ステロイド系消炎鎮痛薬を含む水中油型乳化組成物
DE4140474C2 (de) * 1991-12-09 1995-07-13 Schuelke & Mayr Gmbh Hautpflegeadditiv
DE4339368A1 (de) * 1993-11-18 1995-05-24 Henkel Kgaa Glycerinoctylether in Tensidmischungen
US5653970A (en) * 1994-12-08 1997-08-05 Lever Brothers Company, Division Of Conopco, Inc. Personal product compositions comprising heteroatom containing alkyl aldonamide compounds
US6033652A (en) * 1996-05-15 2000-03-07 Henkel Kommanditgesellschaft Auf Aktien Hair-treatment formulations
US6221816B1 (en) * 1998-12-25 2001-04-24 Kao Corporation Detergent composition comprising a monoglyceryl ether
JP3371098B2 (ja) * 1999-11-04 2003-01-27 花王株式会社 洗浄剤組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03032931A1 *

Also Published As

Publication number Publication date
US20040197294A1 (en) 2004-10-07
WO2003032931A1 (fr) 2003-04-24
DE10150728A1 (de) 2003-04-17
JP2005509617A (ja) 2005-04-14

Similar Documents

Publication Publication Date Title
EP1301172B1 (fr) Opacifiants de faible viscosite exempts de tensioactifs anioniques
WO2003032931A1 (fr) Preparations cosmetiques et / ou pharmaceutiques
EP1434558A1 (fr) Preparations cosmetiques et/ou pharmaceutiques surgraissantes
EP1395229A2 (fr) Epaississant destine a des produits de soins capillaires
EP1434559B1 (fr) Preparations cosmetiques et/ou pharmaceutiques
EP1395643B1 (fr) Melanges d'agents tensioactifs
DE10150725A1 (de) Aniontensidfreie niedrigviskose Trübungsmittel
EP1372579B1 (fr) Serviettes de nettoyage pour soins capillaires
WO2003032930A1 (fr) Shampooing conditionneur
WO2003079794A1 (fr) Utilisation d'extraits d'olivier dans des produits de lavage, de rinçage et de nettoyage
DE10310381A1 (de) Tensidmischungen
EP1434564A1 (fr) Compositions cosmetiques et / ou pharmaceutiques
WO2003015742A1 (fr) Produits nettoyants contenant des acides gras
WO2009112061A1 (fr) Tensio-actifs cationiques présentant des propriétés améliorées
EP3930670B1 (fr) Cires nacrées biosourcées
WO2003066017A1 (fr) Preparations de lavage contenant des huiles vegetales
EP1374845A1 (fr) Préparations cosmétiques
EP1235553A1 (fr) Preparations cosmetiques ou pharmaceutiques contenant des monoesters d'acide dicarboxylique
EP3749280A1 (fr) 1,2 diols pour renforcer la mousse de produits de nettoyage cosmétiques pour la peau et les cheveux
DE10117501A1 (de) Mineralölhaltige Waschzubereitungen
DE10259401A1 (de) Wässrige Tensidzubereitungen
WO2002038124A1 (fr) Utilisation de tensioactifs amphoteres
DE10306838A1 (de) Haarbehandlungsmittel
WO2003051321A1 (fr) Produits de coloration capillaire
WO2001001953A1 (fr) Esterquats encapsules pro-liposomaux

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040403

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COGNIS IP MANAGEMENT GMBH

17Q First examination report despatched

Effective date: 20050511

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050922